RNA, U6 small nuclear 391, pseudogene (RNU6-391P)

RNA, U6 small nuclear 391, pseudogene (RNU6-391P) is classified as a pseudogene of the U6 small nuclear RNA (snRNA) family[1]. U6 snRNA plays a critical role as a core component of the spliceosome, essential for pre-mRNA splicing in eukaryotes, but this specific gene, RNU6-391P, is noncoding and annotated as a pseudogene, meaning it is not functional as a protein or structural RNA and does not participate directly in biological pathways[1][5]. U6 snRNA and its functional relatives are highly conserved and essential for cellular viability, but many nonfunctional pseudogenes of U6 (such as RNU6-391P) exist in the human genome as evolutionary remnants or "back-ups"[5]. Pseudogenes like RNU6-391P generally do *not* code for functional proteins or RNAs, though mounting evidence suggests some pseudogenes may have regulatory roles—such as acting as miRNA decoys, antisense RNAs, or competing endogenous RNAs in some contexts—however, there is no specific evidence attributing such functions to RNU6-391P in the current scientific literature[2]. Most U6 snRNA pseudogenes are considered transcriptionally silent and lack biological or therapeutic relevance. RNU6-391P is not a therapeutic target, receptor, enzyme, or transporter, nor has it been associated with drug interactions, biomarker roles, or therapeutic interventions. It is not considered to have direct clinical or pharmacological relevance at this time[1]. It is important to note that while the *class* of pseudogenes might sometimes act in disease mechanisms (such as cancer-related gene regulation for certain pseudogenes[2]), this is not specifically established for RNU6-391P. Summary of issues: - RNU6-391P is correctly transcribed as a pseudogene and not as a functional target. - It is not therapeutically actionable and should not be referred to as a receptor or functional molecule. - There is no evidence for direct biological, disease, or clinical relevance for this gene.

Other names

RNU6-391P